The NPC1L1/NPC2 combination was also discovered as a separate prognostic factor for OS and TTR in postoperative HCC patients, and this study was the first to reveal the prognostic usefulness of NPC1L1 in HCC. This evidence concerns the gene TTR and hepatocellular carcinoma.